Denosumab biosimilar in postmenopausal osteoporotic women: A randomized, assessor-blind, active-controlled clinical trial

OBJECTIVE: The study assessed the efficacy, safety, pharmacokinetic (PK), and immunogenicity profiles of denosumab-biosimilar and denosumab-reference in postmenopausal osteoporotic women from India. MATERIALS AND METHODS: In this randomized, assessor-blind, active-control, multicenter trial, 114 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Inderjeet, Jose, Vinu, Patel, Ronak, Arora, Sumit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216120/
https://www.ncbi.nlm.nih.gov/pubmed/33975993
http://dx.doi.org/10.4103/ijp.IJP_346_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216120/
https://www.ncbi.nlm.nih.gov/pubmed/33975993
http://dx.doi.org/10.4103/ijp.IJP_346_19

Ejemplares similares